DUBLIN–()–The report has been added to ResearchAndMarkets.com’s offering.
The global DNA & RNA banking services market size is expected to reach USD 9.29 billion by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
In 2020, the drug discovery market segment of DNA & RNA banking services held the largest share. This high market share is attributed to research on biomarker discovery, scientific progressions in clinical research, and the rising need for drug discovery processes. These banking services support the entire therapy monitoring, disease prevention, and appropriate diagnosis with proper follow-ups.
The improving paradigm shift towards treatment by personalized medicine has further favored the market growth. It involves epi-genomics, proteomics, and metabolomics, which uses DNA and RNA samples for new treatment procedures. These biobanks provide data related to gene correlations to decipher any form of genetic variations.
The therapeutics segment is projected to witness a lucrative market growth over the DNA & RNA banking services study period. This is primarily due to large-scale government-sponsored immunization programs and a surge in infectious diseases, over the past decade. In addition, the increasing demand for storage is expected to propel market growth for DNA & RNA banking services.
This has created enormous opportunities for these data banks for future research on infectious diseases, and immunity pathways. For instance, Oxford Vaccine Center collects both RNA and DNA samples to offer data insights related to infectious diseases, resulting in driving the market growth for the DNA & RNA banking services.
- DNA Genotek Inc.
- 23andMe, Inc.
- ProteoGenex, Inc.
- Infinity Biologix
- deCODE genetics
- Brooks Life Sciences
- LGC Biosearch Technologies
- Amgen Inc.
- Infinity Biologix LLP
- US Biolab Corporation, Inc.
- OraSure Technologies, Inc.
- Thermo Fisher Scientific, Inc.
Key Topics Covered:
2. Executive Summary
3. Research Methodology
3.2. Data Service Types
4. DNA & RNA Banking Services Market Insights
4.1. DNA & RNA Banking Services – Industry snapshot
4.2. DNA & RNA Banking Services Market Dynamics
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. DNA & RNA Banking Services Market Industry trends
5. DNA & RNA Banking Services Market Assessment by Service Type
5.1. Key Findings
5.3. Transportation Service
5.4. Processing Service
5.5. Storage Service
5.6. Quality Control Service
5.7. Data Storage
6. Global DNA & RNA Banking Services Market, by Specimen Type
6.1. Key Findings
6.4. Buccal Swabs & Hair Follicles
7. Global DNA & RNA Banking Services Market, by Application
7.1. Key Findings
7.4. Drug Discovery & Clinical Research
7.5. Clinical Diagnostics
7.6. Other Applications
8. DNA & RNA Banking Services Market Assessment by End Use
8.1. Key Findings
8.3. Academic Research
8.4. Pharmaceutical & Biotechnology Companies
8.5. Hospitals & Diagnostic Centers
9. DNA & RNA Banking Services Market Assessment by Geography
9.1. Key findings
9.3. DNA & RNA Banking Services Market – North America
9.4. DNA & RNA Banking Services Market – Europe
9.5. DNA & RNA Banking Services Market – Asia-Pacific
9.6. DNA & RNA Banking Services Market – Middle East & Africa
9.7. DNA & RNA Banking Services Market – Latin America
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
11. Company Profiles
For more information about this report visit